Skip to content

Nihon Kohden A1411-SA203PURecalls & reported problems

APK Technology Co.,Ltd. · Nihon Kohden Compatible Reusable SpO2 Sensor, Adult Soft Tip · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 06946725526453), received between Dec 8, 2023 and Dec 8, 2023 — classified as 1 malfunction.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 1 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • No Apparent Adverse Event1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionDec 8, 2023No Apparent Adverse Event; No Apparent Adverse Event

    DESCRIBE EVENT : SPO2 READING LOW. IT WAS NOTED THAT THE SPO2 WAS READING LOWER THAN EXPECTED ON PTS. IT WAS RECHECKED WITH ANOTHER PULSE OXIMETER THAT GAVE A READING MORE IN LINE WITH THE PT'S PRESENTATION AND SHOWED A SIGNIFICANT DIFFERENCE. THE EXPECTED VARIANCE WAS GREATER THAN (B)(4). COMPLETED IN HOSPITAL COMPARING WITH ANOTHER TRUSTED DEVICE. INVESTIGATION SITUATION: 1. ON SEPTEMBER 15, 2023, OUR COMPANY RECEIVED AN EMAIL NOTIFICATION FROM THE FDA TO NOTIFY THE MDR REPORT, AND IMMEDIATELY ORGANIZED AN INVESTIGATION AFTER RECEIPT, AND FOUND THAT THE PRODUCT SERIAL NUMBER WAS NOT PROVIDED IN THE MDR REPORT, WHICH COULD NOT BE TRACED BACK TO THE FAILURE OF THE SPECIFIC BATCH OF PRODUCTS. OUR COMPANY IMMEDIATELY CONTACTED THE AGENCY WHO DID THE REPORT BY E-MAIL, AND AT THE SAME TIME CONTACTED THE DEALER WHO SOLD THE PRODUCT BY E-MAIL TO INQUIRE ABOUT THE RELEVANT SERIAL NUMBER INFORMATION AND USAGE; 2. I DID NOT RECEIVE ANY FEEDBACK 3 DAYS AFTER THE EMAIL WAS SENT, AND I SENT ANOTHER EMAIL TO FOLLOW UP ON (B)(6), 2023; 3. ON (B)(6), 2023, WE RECEIVED FEEDBACK FROM THE CUSTOMER (THE DISTRIBUTOR OF THE PRODUCT): THE SERIAL NUMBER INFORMATION OF THE PRODUCT COULD NOT BE PROVIDED, A

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18289188 ↗

Other Oximeter devices

All Oximeter devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page